The U.S. Centers for Disease Control and Prevention (CDC) states that stroke, cirrhosis, diabetes, ischemic heart disease, chronic kidney disease, lower respiratory infections, and neonatal disorders are the leading causes of death in Saudi Arabia. According to the Ministry of Health, under the Kingdom of Saudi Arabia, diabetes is one of the most prevalent diseases in the country. As per the Ministry, diabetes causes cardiovascular diseases (CVDs), nerve damage, kidney damage, eye damage, cancer, and Alzheimer's disease among the affected population. 

A majority of chronic diseases caused due to diabetes require surgeries, therefore, the increasing incidence of chronic diseases will help the Saudi Arabian surgical sutures market to progress at 3.6% CAGR during 2018–2023.  As diabetes and chronic diseases are extremely common among old people, a surge in their population will also create a huge requirement for surgical sutures in Saudi Arabia in the foreseeable future.

Get More Insights: Saudi Arabia Surgical Sutures Market Revenue Estimation and Growth Forecast Report

At present, companies operating in the Saudi Arabian surgical sutures market are focusing on mergers and acquisitions to offer improved products that can be used in general surgeries, orthopedic surgeries, gynecological surgeries, CVD surgeries, and ophthalmic surgeries. For instance, in January 2016, Surgical Specialties Corporation acquired all the affiliated entities and shares of FSSB Chirurgische Nadeln GmbH, a suture and needle manufacturing company, for $147 million. Through this acquisition, the former aims to expand its needle business by using the proprietary technology of the latter. 

Thus, the rising cases of chronic diseases and burn injuries and the increasing number of hospitals and healthcare professionals will create a huge requirement for surgical sutures in Saudi Arabia in the foreseeable future.